EPTIFIBATIDE for Percutaneous coronary intervention: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 17 adverse event reports in the FDA FAERS database where EPTIFIBATIDE was used for Percutaneous coronary intervention.
Most Reported Side Effects for EPTIFIBATIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product use in unapproved indication | 61 | 13.2% | 0 | 1 |
| Thrombocytopenia | 58 | 12.6% | 0 | 24 |
| Drug ineffective | 39 | 8.4% | 9 | 22 |
| Off label use | 31 | 6.7% | 1 | 4 |
| Haemoglobin decreased | 30 | 6.5% | 3 | 15 |
| Haemorrhage | 28 | 6.1% | 5 | 7 |
| Vascular stent thrombosis | 19 | 4.1% | 0 | 16 |
| Condition aggravated | 14 | 3.0% | 7 | 10 |
| Gastrointestinal haemorrhage | 14 | 3.0% | 1 | 9 |
| Haematoma | 14 | 3.0% | 4 | 9 |
| Product use issue | 14 | 3.0% | 1 | 2 |
| Hypotension | 13 | 2.8% | 6 | 8 |
| Pulmonary alveolar haemorrhage | 13 | 2.8% | 6 | 7 |
| Subarachnoid haemorrhage | 13 | 2.8% | 3 | 7 |
| Haemoptysis | 12 | 2.6% | 2 | 7 |
Other Indications for EPTIFIBATIDE
Antiplatelet therapy (60)
Product used for unknown indication (57)
Acute myocardial infarction (36)
Cerebral artery occlusion (29)
Thrombosis (26)
Coronary artery thrombosis (18)
Myocardial infarction (13)
Acute coronary syndrome (12)
Thrombosis in device (12)
Ischaemic stroke (11)
Other Drugs Used for Percutaneous coronary intervention
PRASUGREL (376)
CLOPIDOGREL BISULFATE (356)
TICAGRELOR (297)
ASPIRIN (227)
BIVALIRUDIN (159)
CANGRELOR (94)
HEPARIN (86)
ABCIXIMAB (49)
INVESTIGATIONAL PRODUCT (46)
IODIXANOL (29)